BR112017000142A2 - ajuste de ph para melhorar recuperação de criopreservação de bancos de células - Google Patents

ajuste de ph para melhorar recuperação de criopreservação de bancos de células

Info

Publication number
BR112017000142A2
BR112017000142A2 BR112017000142A BR112017000142A BR112017000142A2 BR 112017000142 A2 BR112017000142 A2 BR 112017000142A2 BR 112017000142 A BR112017000142 A BR 112017000142A BR 112017000142 A BR112017000142 A BR 112017000142A BR 112017000142 A2 BR112017000142 A2 BR 112017000142A2
Authority
BR
Brazil
Prior art keywords
adjustment
cell bank
improve cell
cryopreservation recovery
recovery
Prior art date
Application number
BR112017000142A
Other languages
English (en)
Other versions
BR112017000142B1 (pt
Inventor
MEIER Angela
Calhoun Kara
COYNE Marcia
DUFFY Phillip
J Meier Steven
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BR112017000142A2 publication Critical patent/BR112017000142A2/pt
Publication of BR112017000142B1 publication Critical patent/BR112017000142B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fuel Cell (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

são fornecidos aqui os métodos de congelamento de células de mamífero para o armazenamento ou melhoria da recuperação de criopreservação dos bancos de células compreendendo congelamento de células de mamíferos em um meio de congelamento tendo um ph de 6,7 a 8,5.
BR112017000142-0A 2014-07-09 2015-07-09 Métodos para melhorar a recuperação por descongelamento de bancos de células e para congelamento de células cho para armazenamento, grupo de células cho para o congelamento de células de mamíferos, e banco de células BR112017000142B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462022392P 2014-07-09 2014-07-09
US62/022,392 2014-07-09
PCT/US2015/039757 WO2016007752A1 (en) 2014-07-09 2015-07-09 Ph adjustment to improve thaw recovery of cell banks

Publications (2)

Publication Number Publication Date
BR112017000142A2 true BR112017000142A2 (pt) 2017-11-07
BR112017000142B1 BR112017000142B1 (pt) 2021-08-17

Family

ID=53872132

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017000142-0A BR112017000142B1 (pt) 2014-07-09 2015-07-09 Métodos para melhorar a recuperação por descongelamento de bancos de células e para congelamento de células cho para armazenamento, grupo de células cho para o congelamento de células de mamíferos, e banco de células

Country Status (19)

Country Link
US (3) US10602739B2 (pt)
EP (2) EP3777535A1 (pt)
JP (3) JP6826975B2 (pt)
KR (1) KR102355306B1 (pt)
CN (1) CN106686977B (pt)
AU (1) AU2015287760B2 (pt)
BR (1) BR112017000142B1 (pt)
CA (1) CA2953154C (pt)
ES (1) ES2825574T3 (pt)
HR (1) HRP20201663T1 (pt)
IL (1) IL249659B (pt)
MX (1) MX2017000231A (pt)
NZ (1) NZ765734A (pt)
PL (1) PL3166401T3 (pt)
RU (1) RU2714759C2 (pt)
SG (1) SG11201700097WA (pt)
SI (1) SI3166401T1 (pt)
WO (1) WO2016007752A1 (pt)
ZA (1) ZA201700178B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106954623A (zh) * 2016-01-11 2017-07-18 华北制药集团新药研究开发有限责任公司 一种哺乳动物悬浮细胞的冻存溶液及冻存方法
CN106119186B (zh) * 2016-06-24 2019-10-08 肇庆大华农生物药品有限公司 一种用于全悬浮培养mdck细胞的无血清培养基及其制备方法
KR102236427B1 (ko) * 2019-06-05 2021-04-06 연세대학교 산학협력단 오가노이드의 동결 보존용 조성물
EP3795672A1 (en) * 2019-09-18 2021-03-24 Sartorius Stedim Biotech GmbH System and method for the generation of high cell density seed culture

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US5672347A (en) 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
WO1989012463A1 (en) 1988-06-21 1989-12-28 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DK0463151T3 (da) 1990-01-12 1996-07-01 Cell Genesys Inc Frembringelse af xenogene antistoffer
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
DK0546073T3 (da) 1990-08-29 1998-02-02 Genpharm Int Frembringelse og anvendelse af transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
DE69232944T2 (de) 1991-08-14 2003-12-24 Genentech Inc Veränderte Immunglobuline für spezifische FC-Epsilon Rezeptoren
WO1993014191A1 (en) * 1992-01-21 1993-07-22 Cryopharm Corporation Method of freezing cells and cell-like materials
JPH0646840A (ja) * 1992-08-04 1994-02-22 Nippon Zenyaku Kogyo Kk 細胞凍結保存液
JPH08500826A (ja) 1992-08-21 1996-01-30 ジェネンテク，インコーポレイテッド Ｌｆａ−１仲介疾患を処置する方法
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
ES2108566T3 (es) 1993-12-10 1997-12-16 Genentech Inc Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos.
JP3825798B2 (ja) 1994-01-18 2006-09-27 ジェネンテク，インコーポレイテッド ＩｇＥアンタゴニストを用いる寄生虫感染症の治療法
EP0749488A1 (en) 1994-03-03 1996-12-27 Genentech, Inc. Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
EP0822830B1 (en) 1995-04-27 2008-04-02 Amgen Fremont Inc. Human anti-IL-8 antibodies, derived from immunized xenomice
EP0823941A4 (en) 1995-04-28 2001-09-19 Abgenix Inc HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
CA2222231A1 (en) 1995-06-07 1996-12-19 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth of tumors
JP4864175B2 (ja) 1996-01-23 2012-02-01 ジェネンテック， インコーポレイテッド 発作に関する抗―ｃｄ１８抗体
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
DE122004000047I2 (de) 1996-11-27 2006-06-14 Genentech Inc Humanisierte anti-koerper gegen CD11A
ES2301183T3 (es) 1996-12-03 2008-06-16 Amgen Fremont Inc. Anticuerpo completamente humano que se une al receptor del egfr.
KR100816621B1 (ko) 1997-04-07 2008-03-24 제넨테크, 인크. 항-ｖｅｇｆ 항체
ATE370232T1 (de) 1997-05-15 2007-09-15 Genentech Inc Anti-apo-2 antikörper
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
US6485959B1 (en) * 1998-10-07 2002-11-26 Cedars Sinai Medical Center Cell preconditioning and cryopresevation medium
US20030049840A1 (en) * 1998-10-07 2003-03-13 Demetriou Achilles A. Cell preconditioning and cryopreservation medium
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
DK1650307T3 (da) * 1999-09-27 2010-10-04 Genentech Inc Fremgangsmåde til fremstilling af rekombinante proteiner ved anvendelse af apoptoseinhibitorer
NZ518477A (en) 1999-10-29 2004-10-29 Genentech Inc Isolated anti-prostate stem cell antigen (PSCA) antibodies that internalise upon binding to PSCA on a mammalian cell, including a PSCA-expressing tumour cell, in vivo
US7208265B1 (en) * 1999-11-24 2007-04-24 Xy, Inc. Method of cryopreserving selected sperm cells
US20060257842A1 (en) * 2003-05-29 2006-11-16 Pettegrew Jay W Cryopreservation media and molecules
US20050250088A1 (en) * 2004-03-25 2005-11-10 Boldt Jeffrey P Cryopreservation media
US9055739B2 (en) 2004-09-24 2015-06-16 Seiren Kabushiki Kaisha Compositions for cryopreservation of cells
JP4588598B2 (ja) * 2004-09-24 2010-12-01 セーレン株式会社 細胞凍結保存用組成物
SI1820022T1 (sl) * 2004-11-10 2009-10-31 Boehringer Ingelheim Pharma Uporaba pretočne citometrične analize za optimiziranje celičnih bančnih strategij za celice CHO
JP5763288B2 (ja) * 2005-11-17 2015-08-12 日本全薬工業株式会社 細胞保存用水溶液
WO2007077563A2 (en) * 2006-01-04 2007-07-12 Do-Coop Technologies Ltd. Solid-fluid composition
JP4977389B2 (ja) * 2006-03-22 2012-07-18 シスメックス株式会社 細胞保存液及び細胞保存方法
AP2009005028A0 (en) * 2007-04-10 2009-12-31 Univ Tulane Soluble and membrane-anchored forms of lassa virussubunit proteins
WO2011047380A2 (en) * 2009-10-16 2011-04-21 Mehmet Toner Methods for the cryopreservation of mammalian cells
WO2011089391A1 (en) * 2010-01-21 2011-07-28 Cambridge Enterprise Limited Mammalian cell preservation methods
CL2010000920A1 (es) * 2010-08-30 2010-12-17 Metodo para criopreservar espermatozoides humanos libres de plasma seminal, mediante un proceso rapido y simple de vitrificacion - desvitrificacion aseptica; un kit portable para el montaje del metodo.
RU2508397C1 (ru) * 2012-10-04 2014-02-27 Федеральное Государственное Бюджетное Учреждение Науки Институт Биохимической Физики Им. Н.М. Эмануэля Российской Академии Наук (Ибхф Ран) Способ криоконсервации клеток фототрофных микроорганизмов
EP2721930A1 (en) * 2012-10-19 2014-04-23 Serumwerk Bernburg AG Solution for cryopreservation, method of manufacturing the same, and its use
PT3470018T (pt) * 2013-03-13 2021-10-04 Stratatech Corp Criopreservação de substitutos de pele humana viáveis
WO2015150394A1 (en) * 2014-04-01 2015-10-08 Pharmacosmos A/S Cryoprotective agent, cryoprotective and cryopreserved compositions, uses thereof, and methods of cryopreservation
US9813410B2 (en) 2014-06-26 2017-11-07 Rakuten, Inc. Information processing apparatus, information processing method, and information processing program

Also Published As

Publication number Publication date
IL249659B (en) 2019-09-26
JP2023075125A (ja) 2023-05-30
CN106686977A (zh) 2017-05-17
HRP20201663T1 (hr) 2020-12-25
US20220151221A1 (en) 2022-05-19
EP3777535A1 (en) 2021-02-17
RU2017104107A (ru) 2018-08-09
KR20170027831A (ko) 2017-03-10
EP3166401B1 (en) 2020-08-19
MX2017000231A (es) 2017-06-27
IL249659A0 (en) 2017-02-28
AU2015287760B2 (en) 2019-06-20
KR102355306B1 (ko) 2022-01-24
NZ727705A (en) 2023-12-22
WO2016007752A1 (en) 2016-01-14
BR112017000142B1 (pt) 2021-08-17
JP2020072668A (ja) 2020-05-14
EP3166401A1 (en) 2017-05-17
US10602739B2 (en) 2020-03-31
JP6826975B2 (ja) 2021-02-10
CN106686977B (zh) 2022-03-25
SI3166401T1 (sl) 2020-11-30
ES2825574T3 (es) 2021-05-17
US20200315162A1 (en) 2020-10-08
RU2017104107A3 (pt) 2019-02-15
AU2015287760A1 (en) 2017-02-02
JP2017521075A (ja) 2017-08-03
RU2714759C2 (ru) 2020-02-19
CA2953154C (en) 2023-03-14
ZA201700178B (en) 2020-05-27
NZ765734A (en) 2024-01-26
US20170112122A1 (en) 2017-04-27
PL3166401T3 (pl) 2021-01-25
SG11201700097WA (en) 2017-02-27
CA2953154A1 (en) 2016-01-14

Similar Documents

Publication Publication Date Title
BR112017022045A2 (pt) composição e kits para matrizes de microgel pseudoplástico
BR112019000512A2 (pt) anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, composição, métodos de tratamento de uma doença, para produzir um anticorpo biespecífico e para detectar se a reticulação entre as células que expressam cd40 e cd137 ocorre em uma amostra, uso de um anticorpo multiespecífico, e, kit
TR201900776T4 (tr) Memeli hücre kültürlerinin hasadına ilişkin yöntem.
BR112015021189A2 (pt) métodos de banco de células de alta densidade
CL2015003599A1 (es) Solucion que contiene theralosa y dextrano para transplantar celulas de mamiferos
BR112017000142A2 (pt) ajuste de ph para melhorar recuperação de criopreservação de bancos de células
WO2015047484A3 (en) Electrochemical systems and methods for harvesting heat energy
EP3489351A4 (en) CELL CULTIVATION METHOD, SUSPENDED CELL ELIMINATION METHOD AND METHOD FOR KILLING SUSPENDED CELLS
BR112015021993A2 (pt) composições de cultura celular com antioxidantes e métodos para produção de polipeptídeo
BR112017006533A2 (pt) usos de trealose em suspensões celulares
EP4234032A3 (en) Induction medium and methods for stem cell culture and therapy
WO2019126641A3 (en) Modulation of frataxin expression
BR112017001696A2 (pt) composições de célula-tronco e métodos de produção de células-tronco para aplicações terapêuticas
BR112019001409A2 (pt) células renais bioativas para o tratamento de doença renal crônica
BR112016021739A2 (pt) Método para preparar um poloxâmero para uso em um meio de cultura de célula
WO2016176652A3 (en) Modified stem cells and uses thereof
AR121644A2 (es) Molécula de ácido nucleico recombinante, vector, célula hospedante, polipéptido recombinante, composición y método relacionado
MX2019000114A (es) Uso de neutralizadores de gama-cetoaldehidos reactivos para prolongar la vida util de la celula y el ciclo sano.
BR112021020501A2 (pt) Meio de cultura celular para células eucarióticas
RU2013121503A (ru) Способ защиты клеток от апоптоза
BR112018070645A2 (pt) células de levedura recombinante, métodos para produzir uma célula de levedura e método para produzir um composto alvo
Li et al. Role of caspase-3 in apoptosis of human umbilical vein endothelial cell induced by heat stress
TH166146A (th) สารละลายซึ่งมีทรีฮาโลสและเดกซ์แทรนสำหรับการปลูกถ่ายเซลล์สัตว์เลี้ยงลูกด้วยนม
RU2013133363A (ru) Способ профилактики повреждения биологических мембран
RU2015109582A (ru) Способ микробиологического синтеза пептидных комплексов метаболитов микроорганизмов

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/07/2015, OBSERVADAS AS CONDICOES LEGAIS.